Centre for Addiction and Mental Health
33 Russell St., Main Building, 1st floor
Toronto, ON M5S 2S1
416-535-8501 ext. email@example.com
Dr. Anne Bassett is Director of the Clinical Genetics Research Program in the Clinical Research Department and Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH. She is also a Senior Scientist at the Toronto General Research Institute, holds the Dalglish Chair at the University Health Network, and is a Professor of Psychiatry at the University of Toronto.
Areas of Research
Dr. Bassett is an internationally renowned expert in the genetics of schizophrenia and other complex developmental disorders, including congenital cardiac disease. She is the principal investigator of studies that aim to understand the genetic architecture of schizophrenia and characterize clinically relevant genetic subtypes of schizophrenia. The goal is to gain new insights into the mechanisms of illness that will help develop new treatments. Dr. Bassett has pioneered studies of a molecular subtype of schizophrenia known as 22q11.2 deletion syndrome. Individuals born with a 22q11.2 deletion have a one-in-four chance of developing schizophrenia. About one out of every 100 patients with schizophrenia has a 22q11.2 deletion that may be found with a standard clinical blood test. Translating genetic research findings directly into clinical practice is an exciting area of her research that has a strong medical focus. Dr. Bassett's active career also includes teaching at all levels and public service, including for the Schizophrenia Society of Canada.
View Dr. Bassett's publications on PubMed